The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of acquired resistance to lapatinib in HER2-positive breast cancer cells on the Bcl-2 family members MCL-1 and BAX.
Alex J. Eustace
No relevant relationships to disclose
Brigid Browne
No relevant relationships to disclose
Stephen F. Madden
No relevant relationships to disclose
Lorraine O'Driscoll
No relevant relationships to disclose
Martina McDermott
No relevant relationships to disclose
Neil A. O'Brien
No relevant relationships to disclose
William Watson
No relevant relationships to disclose
John Crown
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Other Remuneration - GlaxoSmithKline
Naomi Walsh
No relevant relationships to disclose
Norma O'Donovan
No relevant relationships to disclose